Engitix4 years after its initial series A round, Engitix has completed a $25 million series A extension, led by Netherton Investments, which invests on behalf of billionaire hedge fund founder Mike Platt. The London-based biotech is developing therapies that target the extracellular matrix (ECM) in solid tumors and fibrosis, an area less crowded than more established drug discovery approaches.
Tag Archive for: fundraising
EQT Life Sciences has closed the LSP Dementia Fund at approximately €260m, 2.6-fold over the target fund size of €100m.
The fourth fund of High-Tech Gründerfonds has reached a final fund volume of €493.8m